Santen Pharmaceutical Home Page

Investor Relations

Select region

Santen Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing and marketing of ophthalmic and anti-rheumatic pharmaceuticals to protect and improve people's eyesight and health. More details...

What's New
May 9, 2013	Santen to launch on May 13 of Sante Beautéye, a new OTC eye drop
May 8, 2013	Notice Concerning Abolition of Retirement Benefit Program for Directors
May 8, 2013	Santen to issue Stock Option to Directors as Stock-Linked Remuneration
May 8, 2013	Name Change of European Subsidiary
May 8, 2013	Notice of the Nomination for Members of the Board of Directors
May 8, 2013	Santen Announces Financial Results for the Year ended March 31, 2013
Apr 26, 2013	Discontinuance and Abolition of Countermeasures to Large-Scale Purchases of the Corporation's Shares (Takeover Defense Measures)
News list

For Shareholders and Investors


	Annual Report

	Santen Brief History